{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:52:27Z","timestamp":1767963147787,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T00:00:00Z","timestamp":1426291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12859-015-0522-3","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T19:59:44Z","timestamp":1426276784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["EGFR Mutant Structural Database: computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib"],"prefix":"10.1186","volume":"16","author":[{"given":"Lichun","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debby D","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor HF","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,14]]},"reference":[{"issue":"21","key":"522_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non\u2013small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129\u201339.","journal-title":"N Engl J Med"},{"issue":"1","key":"522_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/1471-2105-15-310","volume":"15","author":"H Wang","year":"2014","unstructured":"Wang H, Xing F, Su H. Novel image markers for non-small cell lung cancer classification and survival prediction. BMC Bioinform. 2014;15(1):310.","journal-title":"BMC Bioinform"},{"issue":"8 Supplement","key":"522_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1158\/1538-7445.AM2011-1731","volume":"71","author":"W Okamoto","year":"2011","unstructured":"Okamoto W, Okamoto I, Tanaka K, Arao T, Nishio K, Fukuoka M. TAK-701, a humanized monoclonal antibody to HGF, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation. Cancer Res. 2011;71(8 Supplement):1731.","journal-title":"Cancer Res"},{"issue":"4","key":"522_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cllc.2011.09.001","volume":"13","author":"J Bar","year":"2012","unstructured":"Bar J, Onn A. Overcoming molecular mechanisms of resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitors. Clin Lung Cancer. 2012;13(4):267\u201379.","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"522_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.lungcan.2010.08.013","volume":"72","author":"JY Wu","year":"2011","unstructured":"Wu JY, Wu SG, Yang CH, Chang YL, Chang YC, Hsu YC. Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations. Lung Cancer. 2011;72(2):205\u201312.","journal-title":"Lung Cancer"},{"issue":"3","key":"522_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"R Rosell","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012;13(3):239\u201346.","journal-title":"Lancet Oncol"},{"key":"522_CR7","doi-asserted-by":"crossref","unstructured":"Kosaka T, Yamaki E, Mogi A, Kuwano H. Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small-cell lung cancer. BioMed Res Int 2011; doi:10.1155\/2011\/165214.","DOI":"10.1155\/2011\/165214"},{"issue":"6","key":"522_CR8","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1158\/1078-0432.CCR-10-2692","volume":"17","author":"GR Oxnard","year":"2011","unstructured":"Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG. Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation. Clin Cancer Res. 2011;17(6):1616\u201322.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"522_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/humu.20512","volume":"28","author":"D Gu","year":"2007","unstructured":"Gu D, Scaringe WA, Li K, Saldivar JS, Hill KA, Chen Z. Database of somatic mutations in EGFR with analyses revealing indel hotspots but no smoking-associated signature. Hum Mutat. 2007;28(8):760\u201370.","journal-title":"Hum Mutat"},{"issue":"9","key":"522_CR10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/JTO.0b013e31829f684a","volume":"8","author":"VH Lee","year":"2013","unstructured":"Lee VH, Tin VP, Choy TS, Lam KO, Choi CW, Chung LP. Association of Exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer. J Thorac Oncol. 2013;8(9):1148\u201355.","journal-title":"J Thorac Oncol"},{"key":"522_CR11","unstructured":"The Protein Data Bank. [\n                    http:\/\/www.rcsb.org\n                    \n                  ]"},{"issue":"6","key":"522_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.str.2007.04.014","volume":"15","author":"LW Yang","year":"2007","unstructured":"Yang LW, Eyal E, Chennubhotla C, Jee J, Gronenborn AM, Bahar I. Insights into equilibrium dynamics of proteins from comparison of NMR and X-ray data with computational predictions. Structure. 2007;15(6):741\u20139.","journal-title":"Structure"},{"issue":"19","key":"522_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.drudis.2012.06.018","volume":"17","author":"GF Hao","year":"2012","unstructured":"Hao GF, Yang GF, Zhan CG. Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem. Drug Discov Today. 2012;17(19):1121\u20136.","journal-title":"Drug Discov Today"},{"issue":"7","key":"522_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1359-6446(05)03377-5","volume":"10","author":"ZW Cao","year":"2005","unstructured":"Cao ZW, Han LY, Zheng CJ, Ji ZL, Chen X, Lin HH. Computer prediction of drug resistance mutations in proteins. Drug Discov Today. 2005;10(7):521\u20139.","journal-title":"Drug Discov Today"},{"key":"522_CR15","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1038\/srep02855","volume":"3","author":"DD Wang","year":"2013","unstructured":"Wang DD, Zhou W, Yan H, Wong M, Lee V. Personalized prediction of EGFR mutation-induced drug resistance in lung cancer. Sci Rep. 2013;3:2855.","journal-title":"Sci Rep"},{"issue":"4","key":"522_CR16","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/prot.20817","volume":"62","author":"V Yarov\u2010Yarovoy","year":"2006","unstructured":"Yarov\u2010Yarovoy V, Schonbrun J, Baker D. Multipass membrane protein structure prediction using Rosetta. Proteins. 2006;62(4):1010\u201325.","journal-title":"Proteins"},{"key":"522_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/B978-0-12-381270-4.00019-6","volume":"487","author":"A Leaver-Fay","year":"2011","unstructured":"Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R. ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol. 2011;487:545\u201374.","journal-title":"Methods Enzymol"},{"key":"522_CR18","first-page":"193","volume-title":"Computational Intelligence in Bioinformatics and Computational Biology (CIBCB)","author":"W Zhou","year":"2013","unstructured":"Zhou W, Wang DD, Yan H, Wong M, Lee V. Prediction of anti-EGFR drug resistance base on binding free energy and hydrogen bond analysis. In: Computational Intelligence in Bioinformatics and Computational Biology (CIBCB). 2013. p. 193\u20137."},{"key":"522_CR19","volume-title":"AMBER 12","author":"DA Case","year":"2012","unstructured":"Case DA. AMBER 12. San Francisco: University of California; 2012."},{"issue":"3","key":"522_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/prot.22921","volume":"79","author":"EH Kellogg","year":"2011","unstructured":"Kellogg EH, Leaver\u2010Fay A, Baker D. Role of conformational sampling in computing mutation\u2010induced changes in protein structure and stability. Proteins. 2011;79(3):830\u20138.","journal-title":"Proteins"},{"issue":"22","key":"522_CR21","doi-asserted-by":"publisher","first-page":"14116","DOI":"10.1073\/pnas.202485799","volume":"99","author":"T Kortemme","year":"2002","unstructured":"Kortemme T, Baker D. A simple physical model for binding energy hot spots in protein\u2013protein complexes. Proc Natl Acad Sci. 2002;99(22):14116\u201321.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"522_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","volume":"29","author":"MA Mart\u00ed-Renom","year":"2000","unstructured":"Mart\u00ed-Renom MA, Stuart AC, Fiser A, S\u00e1nchez R, Melo F, \u0160ali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomo Struct. 2000;29(1):291\u2013325.","journal-title":"Annu Rev Biophys Biomo Struct"},{"issue":"2","key":"522_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.sbi.2006.02.003","volume":"16","author":"K Ginalski","year":"2006","unstructured":"Ginalski K. Comparative modeling for protein structure prediction. Curr Opin Struct Biol. 2006;16(2):172\u20137.","journal-title":"Curr Opin Struct Biol"},{"issue":"2","key":"522_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0959-440X(97)80027-9","volume":"7","author":"R Sanchez","year":"1997","unstructured":"Sanchez R, \u0160ali A. Advances in comparative protein-structure modelling. Curr Opin Struct Biol. 1997;7(2):206\u201314.","journal-title":"Curr Opin Struct Biol"},{"issue":"suppl 1","key":"522_CR25","doi-asserted-by":"publisher","first-page":"D465","DOI":"10.1093\/nar\/gkq1091","volume":"39","author":"U Pieper","year":"2011","unstructured":"Pieper U, Webb BM, Barkan DT, Schneidman-Duhovny D, Schlessinger A, Braberg H. ModBase, a database of annotated comparative protein structure models, and associated resources. Nucl Acids Res. 2011;39 suppl 1:D465\u201374.","journal-title":"Nucl Acids Res"},{"issue":"3","key":"522_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/138920306777452312","volume":"7","author":"Z Xiang","year":"2006","unstructured":"Xiang Z. Advances in homology protein structure modeling. Curr Protein Pept Sci. 2006;7(3):217\u201327.","journal-title":"Curr Protein Pept Sci"},{"key":"522_CR27","doi-asserted-by":"crossref","unstructured":"Thompson JD, Gibson T, Higgins DG. Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinform 2002; doi:10.1002\/0471250953.bi0203s00.","DOI":"10.1002\/0471250953.bi0203s00"},{"issue":"4","key":"522_CR28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","volume":"16","author":"LJ McGuffin","year":"2000","unstructured":"McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinform. 2000;16(4):404\u20135.","journal-title":"Bioinform"},{"key":"522_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0076-6879(04)83004-0","volume":"383","author":"CA Rohl","year":"2004","unstructured":"Rohl CA, Strauss CE, Misura KM, Baker D. Protein structure prediction using Rosetta. Methods Enzymol. 2004;383:66\u201393.","journal-title":"Methods Enzymol"},{"issue":"13","key":"522_CR30","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312.","journal-title":"J Comput Chem"},{"issue":"2","key":"522_CR31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford S, Dawson E, Forbes S, Clements J, Pettet R, Dogan A. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91(2):355\u20138.","journal-title":"Br J Cancer"},{"issue":"7","key":"522_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2174\/1871520614666140323203140","volume":"14","author":"IS Yadav","year":"2014","unstructured":"Yadav IS, Singh H, Imran KM, Chaudhury A, Raghava GP, Agarwal SM. EGFRIndb: Epidermal Growth Factor Receptor Inhibitor Database. Anti-cancer Agents Med Chem. 2014;14(7):928\u201335.","journal-title":"Anti-cancer Agents Med Chem"},{"key":"522_CR33","doi-asserted-by":"crossref","unstructured":"Ma L, Wang DD, Huang Y, Wong MP, Lee VH, Yan H. Decoding the EGFR mutation-induced drug resistance in lung cancer treatment by local surface geometric properties. Comput Biol Med. 2014; doi:10.1016\/j.compbiomed.2014.06.016","DOI":"10.1016\/j.compbiomed.2014.06.016"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-015-0522-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0522-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0522-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:42:49Z","timestamp":1551184969000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-015-0522-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,14]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1186\/s12859-015-0522-3","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,14]]},"assertion":[{"value":"21 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"85"}}